We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Newborn HBV vaccination rates in the U.S. peaked at 83.5 ...

Arbutus Biopharma targets chronic hepatitis B with Imdusiran, addressing a vast, unmet medical need. Read more on ABUS stock ...

Please provide your email address to receive an email when new articles are posted on . Global HBV incidence and mortality rates dropped from 1990 to 2021 among individuals aged 15 to 49 years.

In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + ...

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.

Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, ...

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Objectives To investigate the real-world incidence of serious infections (SI), herpes zoster (HZ) and hepatitis B virus (HBV) ...

Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...